(January 10, 2023, 12:30 PM EST) -- BOSTON — The First Circuit U.S. Court of Appeals on Jan. 9 affirmed summary judgment that all 482 cases in the Zofran birth defect multidistrict litigation are preempted because there was no newly acquired information about the alleged teratogenicity of the anti-nausea drug....